You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
The actual match rate is significantly higher than the 10 percent rate the researchers anticipated they would see when the study began in 2017.
This is the first US Food and Drug Administration approval for a drug based solely on data from a basket study.
By comparing pre-treatment and post-relapse samples from vemurafenib-treated melanoma patients, researchers uncovered resistance-related cohesin complex mutations.
Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.
Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.
The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.
This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.